The effect of 2 sympatholytic medications - Propranolol and clonidine - On sleep bruxism: Experimental randomized controlled studies

Sleep

Volumn 29, Issue 3, 2006, Pages 307-316

  Huynh, Nelly ^a,b   Lavigne, Gilles J ^a,b   Lanfranchi, Paola A ^a,b   Montplaisir, Jacques Y ^a,b   De Champlain, Jacques ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Autonomic nervous system; Clonidine; Heart rate variability; Propranolol; Sleep bruxism

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; PLACEBO; PROPRANOLOL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRUXISM; CANADA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPOTENSION; MALE; MASSETER MUSCLE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; RR INTERVAL; SLEEP TIME; SPECTROSCOPY; SYMPATHETIC TONE; XEROSTOMIA; DRUG ADMINISTRATION; HEART RATE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; CLONIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART RATE; HUMANS; MALE; POLYSOMNOGRAPHY; PROPRANOLOL; SLEEP BRUXISM;

EID: 33745775062     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/29.3.307     Document Type: Article

References (48)

1. AASM. Sleep Related Bruxism. In:Medicine A. A. o. S., eds. ICSD-2 International classification of sleep disorders, 2nd ed.: Diagnosis and coding manual. Westchester, Illinois:American Academy of Sleep Medicine, 2005:189-192.
2. Lavigne GJ, Manzini C, Kato T. Sleep bruxism. In: Kryger MH, Roth T, Dement WC., eds. Principles and Practice of Sleep Medicine. Philadelphia: Elsevier; 2005:946-59.
3. Lavigne GJ, Montplaisir J. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17:739-43.
4. Lavigne GJ, Kato T, Kolta A, Sessle B. J. Neurobiological mechanisms involved in sleep bruxism. Crit Rev Oral Biol Med 2003;14:30-46.
5. Kato T, Dal-Fabbro C, Lavigne GJ. Current knowledge on awake and sleep bruxism: overview. Alpha Omegan 2003;96:24-32.
6. Clark GT, Beemsterboer PL, Rugh JD. Nocturnal masseter muscle activity and the symptoms of masticatory dysfunction. J Oral Rehabil 1981;8:279-86.
7. Vanderas AP, Menenakou M, Kouimtzis T, Papagiannoulis L. Urinary catecholamine levels and bruxism in children. J Oral Rehabil 1999;26:103-10.
8. Magee KR. Bruxism related to levodopa therapy. JAMA 1970;214:147.
9. Lobbezoo F, Lavigne GJ, Tanguay R, Montplaisir JY. The effect of catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial. Mov Disord 1997;12:73-8.
10. Lavigne G. J, Soucy J. P, Lobbezoo F, Manzini C, Blanchet PJ, Montplaisir JY. Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism. Clin Neuropharmacol 2001;24:145-9.
11. Bader GG, Kampe T, Tagdae T, Karlsson S, Blomqvist M. Descriptive physiological data on a sleep bruxism population. Sleep 1997;20:982-90.
12. Macaluso GM, Guerra P, Di Giovanni G, Boselli M, Parrino L, Terzano M. G. Sleep bruxism is a disorder related to periodic arousals during sleep. J Dent Res 1998;77:565-73.
13. Kato T, Rompré P, Montplaisir JY, Sessle BJ, Lavigne GJ. Sleep bruxism: an oromotor activity secondary to micro-arousal. J Dent Res 2001;80:1940-4.
14. Miyawaki S, Lavigne GJ, Mayer P, Guitard F, Montplaisir JY, Kato T. Association between sleep bruxism, swallowing-related laryngeal movement, and sleep positions. Sleep 2003;26:461-5.
15. Bonnet MH, Arand DL. Heart rate variability: sleep stage, time of night, and arousal influences. Electroencephalogr Clin Neurophysiol 1997;102:390-6.
16. Bonnet MH, Arand DL. Impact of activity and arousal upon spectral EEG parameters. Physiol Behav 2001;74:291-8.
17. Okeson JP, Phillips B. A, Berry DT, Baldwin R. M. Nocturnal bruxing events: a report of normative data and cardiovascular response. J Oral Rehabil 1994;21:623-30.
18. Satoh T, Harada Y. Electrophysiological study on tooth-grinding during sleep. Electroencephalogr Clin Neurophysiol 1973;35:267-75.
19. Tani K, Yoshii N, Yoshino I, Kobayashi E. Electroencephalographic study of parasomnia: sleep-talking, enuresis and bruxism. Physiol Behav 1966;1:241-3.
20. Amir I, Hermesh H, Gavish A. Bruxism secondary to antipsychotic drug exposure: a positive response to propranolol. Clin Neuropharmacol 1997;20:86-9.
21. Sjöholm TT, Lehtinen I, Piha SJ. The effect of propranolol on sleep bruxism: hypothetical considerations based on a case study. Clin Auton Res 1996;6:37-40.
22. Lavigne GJ, Rompré PH, Montplaisir J. Sleep bruxism: validity of clinical research diagnostic criteria in a controlled polysomnographic study. J Dent Res 1996;75:546-52.
23. Velly-Miguel AM, Montplaisir J, Rompré PH, Lund JP, Lavigne GJ. Bruxism and other orofacial movements during sleep. J Craniomand Dis Fac Oral Pain 1992;6:71-81.
24. Kato T, Thie N, Montplaisir J, Lavigne GJ. Bruxism and orofacial movements during sleep. In: Attanasio R, Bailey DR, eds. Dent Clin North Am. Philadelphia: Saunders; 2001:657-84.
25. Kato T, Montplaisir J, Rompré PH, Lavigne GJ. Sequence of EEG and cardiac activation in relation to sleep bruxism: a controlled study. J Dent Res 2001;80:697.
26. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA; 1968.
27. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-84.
28. Dubé C, Rompré PH, Manzini C, Guitard F, de Grandmont P, Lavigne GJ. Quantitative polygraphic controlled study on efficacy and safety of oral splint devices in tooth-grinding subjects. J Dent Res 2004;83:398-403.
29. Lobbezoo F, Lavigne GJ, Gosselin A, Montplaisir J. Acute administration of L-dopa in sleep bruxism: a polysomnographic study with a double-blind crossover design. Sleep Res 1995;24A:132.
30. Lavigne G. J, Rompré P. H, Poirier G, Huard H, Kato T, Montplaisir J. Y. Rhythmic masticatory muscle activity during sleep in humans. J Dent Res 2001;80:443-8.
31. Lavigne GJ, Guitard F, Rompré PH, Montplaisir JY. Variability in sleep bruxism activity over time. J Sleep Res 2001;10:237-44.
32. Elsenbruch S, Harnish MJ, Orr WC. Heart rate variability during waking and sleep in healthy males and females. Sleep 1999;22:1067-71.
33. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043-65.
34. Brandenberger G, Ehrhart J, Piquard F, Simon C. Inverse coupling between ultradian oscillations in delta wave activity and heart rate variability during sleep. Clin Neurophysiol 2001;112:992-6.
35. Lovett E. G, Myklebust J. B. Approximate minimum bias multichannel spectral estimation for heart rate variability. Ann Biomed Eng 1997;25:509-20.
36. Kettunen J, Keltikangas-Jarvinen L. Intraindividual analysis of instantaneous heart rate variability. Psychophysiology 2001;38:659-68.
37. Suzman M. M. Propranolol in the treatment of anxiety. Postgrad Med J 1976;52(Suppl 4):168-74.
38. Szabo B. Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol Ther 2002;93:1-35.
39. van Zwieten, Timmermans PB, eds. The role of alpha-adrenoceptors in the regulation of blood pressure and in the mediation of the anti-hypertensive effects of drugs, in central blood pressure regulation: the role of alpha 2-receptor stimulation. Darmstadt: Steinkopff Verlag; 1983.
40. Kushikata T, Hirota K, Yoshida H, Kubota T, Ishihara H, Matsuki A. Alpha-2 adrenoceptor activity affects propofol-induced sleep time. Anesth Analg 2002;94:1201-6.
41. Grenhoff J, Svensson TH. Clonidine regularizes substantia nigra dopamine cell firing. Life Sci 1988;42:2003-9.
42. Morrow BA, George TP, Roth RH. Noradrenergic alpha-2 agonists have anxiolytic-like actions on stress-related behavior and mesoprefrontal dopamine biochemistry. Brain Res 2004;1027:173-8.
43. Walling SG, Nutt DJ, Lalies MD, Harley CW. Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrus. J Neurosci 2004;24:7421-6.
44. Zhang J, Luo P. Orexin B immunoreactive fibers and terminals innervate the sensory and motor neurons of jaw-elevator muscles in the rat. Synapse 2002;44:106-110.
45. Morilak DA, Jacobs BL. Noradrenergic modulation of sensorimotor processes in intact rats: the masseteric reflex as a model system. J Neurosci 1985;5:1300-6.
46. Katakura N, Chandler SH. Iontophoretic analysis of the pharmacologic mechanisms responsible for initiation and modulation of trigeminal motoneuronal discharge evoked by intra-oral afferent stimulation. Brain Res 1991;549:66-77.
47. Autret A, Minz M, Beillevaire T, Cathala H. P, Schmitt H. Effect of clonidine on sleep patterns in man. Eur J Clin Pharmacol 1977;12:319-22.
48. Gentili A, Godschalk M. F, Gheorghiu D, Nelson K, Julius D. A, Mulligan T. Effect of clonidine and yohimbine on sleep in healthy men: a double-blind, randomized, controlled trial. Eur J Clin Pharmacol 1996;50:463-5.